GLIOGENE is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With GLIOGENE, we may be able learn more about possible genes related to this disease -- and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease -- information that one day we hope will lead to improved treatment, as well as preventive strategies.

GLIOGENE is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study. Find out more...

MD ANDERSON NEWS

  • Wilms' tumor: childhood kidney cancer
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=8164D178-A143-4864-8B90-55904613BE8B  Wilms' tumor is a cancer that develops in the kidney and is the fifth most common cancer in children. Generally there are...
  • Prostate Cancer Moon Shot update
    Download from iTunes: https://itunes.apple.com/us/podcast/prostate-cancer-moon-shot/id431848216?i=319769359&mt=2. The Prostate Cancer Moon Shot at MD Anderson Cancer Center focuses on: reducing overtreatment; combining therapies used in more advanced cases...
  • Lung Cancer Moon Shot update
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=1F0B25E6-9C47-4CE5-B8C9-78F034B6C730 Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach,...